EC Number |
Title |
Organism |
---|
3.1.4.53 | Carboxyamidotriazole A novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases |
Mus musculus |
3.1.4.53 | Carboxyamidotriazole A novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases |
Rattus norvegicus |
3.1.4.53 | Characterization of cAMP-phosphodiesterase activity in bovine seminal plasma |
Bos taurus |
3.1.4.53 | Electrostatic steering enhances the rate of cAMP binding to phosphodiesterase Brownian dynamics modeling |
Homo sapiens |
3.1.4.53 | Inactivation of oncogenic cAMP-specific phosphodiesterase 4D by miR-139-5p in response to p53 activation |
Homo sapiens |
3.1.4.53 | Revisiting bacterial cyclic nucleotide phosphodiesterases cyclic AMP hydrolysis and beyond |
Serratia marcescens |
3.1.4.53 | Revisiting bacterial cyclic nucleotide phosphodiesterases cyclic AMP hydrolysis and beyond |
Escherichia coli |
3.1.4.53 | Role of cAMP and phosphodiesterase signaling in liver health and disease |
Homo sapiens |
3.1.4.53 | Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia |
Homo sapiens |
3.1.4.53 | Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia |
Mus musculus |